# Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis

> **NCT02809183** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tricida, Inc.** · enrollment: 135 (actual)

## Conditions studied

- Acidosis

## Interventions

- **DRUG:** Placebo
- **DRUG:** TRC101

## Key facts

- **NCT ID:** NCT02809183
- **Lead sponsor:** Tricida, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02809183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02809183, "Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02809183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*